Other resources for Studies

• Costs and Economics of patent acquisition, litigation and licensing. Page prepared by Greg Aharonian.
• Index of Papers and Reports from the World Health Organization's Commission on Macroeconomics and Health.
• Fall, 2002. Michael Kremer. Paper published in the Journal of Economic Perspectives, vol. 16, no. 4. Pharmaceuticals and the Developing World.
• December 1, 2002. Panos Institute. Patents, Pills and Public Health - Can TRIPS Deliver?
• September 2002. UK Commission on Intellectual Property Rights Report
• June, 2001. Jean Lanjouw for the Brookings Instutute A Patent Policy for Global Diseases.
• February, 2001. The Economic Impact of Malaria In Peru. Study done by the Peruvian Ministry of Health and USAID.
• August 8-9, 2000. Conference on Pharmaceutical Pricing Practices, Utilization and Cost. This site contains 14 academic papers from participants in the conference. Conference hosted by the US Department of Health and Human Services.
• August, 2000. Mickie I. Hunt. Prescription Drugs and Intellectual Property Protection: Finding the Right Blance Between Access and Inovation. Study done for the National Institute for Health Care Management. Click here for more reports on pharmaceuticals from the NIHCM.
• June 29, 2000, Manon Ress, Tax Deductions for Pharmaceutical Drug Donations
• April 1999, Ensuring Cost-Effective Access to Innovative Pharmaceuticals Do Market Interventions Work? a report prepared by The Boston Consulting Group, Inc., Sponsored by: Warner-Lambert Company

• May, 2001. Statistics from IMS Health. Includes pharmaceutical industry sales figures for the year ending May 1, 2001, broken down by region and by therapeutic class.
• World Bank website for development statistics.
• 2000. CIA. World Factbook Index of country index. Lists macroeconomic and social figures, for coutries.
• Fortune 500 Table on pharmaceutical company returns. (2000 data.)
• Rxlist.com list to top 200 perscriptions, ranked by number of prescriptions in 2000 (not revenue).
• 1999. Drug company expenses broken down by cost, marketing, and research & development.
• 1999, IMS Health, World-Wide Pharmaceutical Market 1999

• September 16, 2002. Jagdish Bhagwati for the Financial Times. Patents and the Poor.
• March 12, 2002. George Monbiot for the Guardian. Companies Now Demanding Intellectual Property Rights Were Built Up Without Them.
• June 20, 2001. Martin Wolf for the Financial Times. The True Price of Saving Lives.